Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

CinCor Pharma

Biotech & Life Sciences · Waltham, United States · Founded 2018 · IPO 2022 Unicorn

Clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases

Valuation
$1.80B
Market cap · 2026

Investors

14 investors on CinCor Pharma's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage
Sofinnova Investments
5AM Ventures
Sofinnova Partners
Series B+ 11 investors entered at this stage
venBio Partners
BVF Partners
CinRx Pharma
General Atlantic
Lilly Asia Ventures
Adage Capital
Omega Funds
Sixty Degree Capital
Rock Springs Capital
Perceptive Advisors
RTW Investments

Global footprint

Where CinCor Pharma has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Patent intelligence

$50M patent portfolio · 19 active families

Estimated portfolio value
$50M
2.8% of market cap · 5.7× the top peer WuXi AppTec ($9M)
19 active patent families
Where CinCor Pharma innovates Combinatorial chemistryPerylene derivativesAldosterone Synthase DeficiencyAldosterone synthaseIsoquinoline

Where CinCor Pharma concentrates vs peers

Each axis is a top-10 topic across CinCor Pharma and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about CinCor Pharma

An AI-synthesized read of the highest-engagement posts about CinCor Pharma on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CinCor Pharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.